Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$62.69 - $88.44 $31,345 - $44,220
-500 Reduced 87.72%
70 $5,000
Q4 2021

Jan 10, 2022

SELL
$77.28 - $99.42 $38,640 - $49,710
-500 Reduced 46.73%
570 $51,000
Q1 2021

Apr 29, 2021

BUY
$72.25 - $168.95 $35,691 - $83,461
494 Added 85.76%
1,070 $80,000
Q4 2020

Jan 15, 2021

BUY
$125.56 - $178.74 $17,578 - $25,023
140 Added 32.11%
576 $98,000
Q3 2020

Oct 21, 2020

BUY
$127.12 - $172.34 $25,424 - $34,468
200 Added 84.75%
436 $61,000
Q2 2020

Jul 10, 2020

BUY
$93.0 - $171.7 $2,325 - $4,292
25 Added 11.85%
236 $38,000
Q1 2020

Apr 15, 2020

BUY
$82.38 - $131.64 $8,649 - $13,822
105 Added 99.06%
211 $21,000
Q2 2019

Aug 07, 2019

BUY
$112.21 - $151.95 $11,221 - $15,194
100 Added 1666.67%
106 $16,000
Q1 2019

Apr 29, 2019

BUY
$106.67 - $151.68 $640 - $910
6 New
6 $1,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.